A compared with PACB: revenue, margins and what each company keeps, and the suppliers and customers both name

AAgilent Technologies, Inc.

Mkt capRevenueRevenue

PACBPacific Biosciences of California, Inc.

Mkt capRevenueRevenue

Compare

AAgilent Technologies, Inc.

PACBPacific Biosciences of California, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±7.9%▲+1.68%×0.22

Q2 FY26±7.7%▲+16.87%×2.19

Q1 FY26±6.4%▼−3.01%×0.47

Nov 25 '25±6.5%▲+2.34%×0.35

PACB

1 of 4at or beyond implied

Reportimpliedrealized× implied

Nov 5 '26±25.8%▼−4.71%×0.18

Q2 FY26±37.4%▼−10.38%×0.28

= impliedA realized, solidPACB realized, hatchedOne scale, both sides: full bar = 38%× = |realized| ÷ impliedSource: market data

Q1 FY26

±12.1%

▼−14.55%

×1.21

Feb 13 '26±16.5%▼−7.07%×0.43

AAgilent Technologies, Inc.

171.73· pre 171.78· delayed

Mkt cap$49.9BRevenue$1.9BQ3 FY26Revenue$6.9BFY25

PACBPacific Biosciences of California, Inc.

2.43· pre 2.42· delayed

Pre-marketNov 5 '26delayed

Mkt cap$792.6MRevenue$41MQ3 FY26Revenue$160MFY25

Compare

Pre-marketNov 5 '26delayed

AAgilent Technologies, Inc.

PACBPacific Biosciences of California, Inc.

171.73pre 171.78delayed

Price

2.43pre 2.42delayed

$49.9B

Mkt cap

$792.6M

Q3 FY26$1.9B

Revenue

$41MQ3 FY26

FY25$6.9B

Revenue

$160MFY25

A171.73vsPACB2.43Pre-marketNov 5 '26delayed